drugset / Trial / NCT03859414
PK of BDP/FF/GB Single-inhaler Triple Therapy in Japanese vs. Caucasians
RandomizedCrossoverQuadruple-blindOther
Summary
The purpose of conducting this study is to obtain PK data of Beclometasone Dipropionate (BDP)/Beclometasone-17-MonoPropionate (B17MP), Formoterol Fumarate (FF) and Glycopyrronium Bromide (GB) after inhalation of CHF 5993 in Japanese as well as Caucasian healthy subjects under the same setting.
Timeline
- Start
- 2019-03-18
- Primary completion
- 2019-07-24
- Completion
- 2019-07-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Formoterol | Other / unclassified | 12 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 48 ug | Inhaled |
| Subject | Glycopyrronium | Unknown | 25 ug | Inhaled |
| Subject | Glycopyrronium | Unknown | 100 ug | Inhaled |
| Subject | beclomethasone dipropionate | Other / unclassified | 200 ug | Inhaled |
| Subject | beclomethasone dipropionate | Other / unclassified | 400 ug | Inhaled |
| Subject | beclomethasone dipropionate | Other / unclassified | 800 ug | Inhaled |